Published in J Immunol on September 15, 2007
Memory regulatory T cells reside in human skin. J Clin Invest (2014) 1.95
Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog (2010) 1.53
Selective priming and expansion of antigen-specific Foxp3- CD4+ T cells during Listeria monocytogenes infection. J Immunol (2009) 1.39
CD4+ T-cell development in a mouse expressing a transgenic TCR derived from a Treg. Eur J Immunol (2009) 1.36
Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients. J Immunol (2009) 1.35
Peripherally induced tregs - role in immune homeostasis and autoimmunity. Front Immunol (2013) 1.24
Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors. Cancer Res (2010) 1.21
Becoming self-aware: the thymic education of regulatory T cells. Curr Opin Immunol (2010) 1.12
CD4(+) CD25(+) Foxp3(+) T regulatory cells with limited TCR diversity in control of autoimmunity. J Immunol (2009) 1.04
A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma. PLoS One (2012) 0.96
Induced regulatory T cells in inhibitory microenvironments created by cancer. Expert Opin Biol Ther (2014) 0.93
Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells. Blood (2010) 0.92
Development of thymically derived natural regulatory T cells. Ann N Y Acad Sci (2010) 0.91
Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells. Transl Res (2008) 0.91
High-throughput sequencing of B- and T-lymphocyte antigen receptors in hematology. Blood (2013) 0.85
Regulatory T-Cell Development in the Human Thymus. Front Immunol (2015) 0.85
Thymus transplantation restores the repertoires of forkhead box protein 3 (FoxP3)+ and FoxP3- T cells in complete DiGeorge anomaly. Clin Exp Immunol (2013) 0.83
The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status. Haematologica (2014) 0.82
Peripheral and local human papillomavirus 16-specific CD8+ T-cell expansions characterize erosive oral lichen planus. J Invest Dermatol (2014) 0.78
Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis. Arthritis Rheumatol (2016) 0.77
Deep sequencing of the TCRB repertoire of human Foxp3(+) and Foxp3(-) T cells suggests that they are completely distinct and non-overlapping. Clin Exp Immunol (2016) 0.75
Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol (2004) 3.50
Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med (2011) 2.93
A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med (2007) 2.41
Rituximab for patients with refractory mucous membrane pemphigoid. Arch Dermatol (2011) 2.19
Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas. Arch Dermatol (2004) 2.08
A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest (2005) 1.77
A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest (2007) 1.67
Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). J Infect Dis (2009) 1.49
Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1. PLoS Pathog (2010) 1.37
Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol (2007) 1.36
Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. Blood (2005) 1.34
Vaccination-induced cutaneous pseudolymphoma. J Am Acad Dermatol (2005) 1.33
MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog (2013) 1.32
Staphylococcal enterotoxin-like toxins U2 and V, two new staphylococcal superantigens arising from recombination within the enterotoxin gene cluster. Infect Immun (2006) 1.24
Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection. J Exp Med (2011) 1.22
Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome). Int J Cancer (2004) 1.17
Ipilimumab-induced acute severe colitis treated by infliximab. Melanoma Res (2013) 1.16
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells. J Immunol (2005) 1.13
Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C). J Invest Dermatol (2003) 1.13
The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. Oncogene (2002) 1.13
Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1RN mutations. Ann Intern Med (2010) 1.11
Human TCR alpha/beta+ CD4-CD8- double-negative T cells in patients with autoimmune lymphoproliferative syndrome express restricted Vbeta TCR diversity and are clonally related to CD8+ T cells. J Immunol (2008) 1.09
Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay. J Immunol Methods (2002) 1.06
Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae. J Am Acad Dermatol (2002) 1.01
Psoriasis induced by anti-tumor necrosis factor therapy: a class effect? J Rheumatol (2007) 1.00
TNF alpha antagonist therapy and safety monitoring. Joint Bone Spine (2011) 0.96
Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort. BMC Public Health (2012) 0.96
Detection of low-frequency human antigen-specific CD4(+) T cells using MHC class II multimer bead sorting and immunoscope analysis. Eur J Immunol (2004) 0.95
Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity. Blood (2005) 0.95
Cancer risk in immune-mediated inflammatory diseases (IMID). Mol Cancer (2013) 0.95
Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia. PLoS One (2008) 0.95
HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk. PLoS One (2008) 0.95
MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis. J Immunol (2011) 0.94
Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents. Clin Cancer Res (2008) 0.93
Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort. Oncoimmunology (2013) 0.92
B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev (2007) 0.90
Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population. PLoS One (2013) 0.90
Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. Medicine (Baltimore) (2003) 0.89
Analysis of apoptotic pathways by multiparametric flow cytometry: application to HIV infection. Methods Enzymol (2008) 0.88
IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells. Proc Natl Acad Sci U S A (2011) 0.87
Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies? AIDS Rev (2011) 0.87
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV. AIDS (2012) 0.86
Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4⁺ T-cell repertoire selection. Nat Commun (2012) 0.86
VH gene usage and CDR3 analysis of B cell receptor in the peripheral blood of patients with PBC. Autoimmunity (2008) 0.85
T cell repertoire diversity is required for relapses in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol (2007) 0.85
Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome. PLoS One (2010) 0.85
Lack of control of T cell apoptosis under HAART. Influence of therapy regimen in vivo and in vitro. AIDS (2002) 0.85
Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore) (2009) 0.84
Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma. Blood (2012) 0.84
Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody). Arch Dermatol (2004) 0.84
Paradoxical adverse effects of anti-TNF-alpha treatment: onset or exacerbation of cutaneous disorders. Expert Rev Clin Immunol (2009) 0.84
Hidradenitis suppurativa associated with spondyloarthritis -- results from a multicenter national prospective study. J Rheumatol (2014) 0.83
A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophils. PLoS One (2009) 0.82
Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis. Arthritis Rheum (2008) 0.82
Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases. Arch Dermatol (2012) 0.81
Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy. Clin Infect Dis (2013) 0.80
Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol (2007) 0.80
Vemurafenib-induced neutrophilic panniculitis. Melanoma Res (2012) 0.80
Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis. Melanoma Res (2009) 0.80
Solar urticaria treated with intravenous immunoglobulins. J Am Acad Dermatol (2011) 0.79
Severe FOXP3+ and naïve T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency. Gastroenterology (2007) 0.79
Imatinib-induced hand-foot syndrome in a patient with metastatic gastrointestinal stromal tumor. Arch Dermatol (2008) 0.79
A nonsecreted variant of interleukin-4 is associated with apoptosis: implication for the T helper-2 polarization in HIV infection. Blood (2002) 0.79
Bcl-xL gene expression correlated with lower apoptotic cell numbers and shorter progression-free survival in PCFCL. J Invest Dermatol (2009) 0.79
Incidence, risk factors, and severity of herpesvirus infections in a cohort of 121 patients with primary dermatomyositis and dermatomyositis associated with a malignant neoplasm. Arch Dermatol (2009) 0.79
National survey of psoriasis flares after 2009 monovalent H1N1/seasonal vaccines. Dermatology (2014) 0.78
Vemurafenib in the French temporary authorization for use metastatic melanoma cohort: a single-centre trial. Melanoma Res (2014) 0.78
Sweet syndrome revealing microscopic polyangiitis. Rheumatology (Oxford) (2012) 0.77
Thimerosal compromises human dendritic cell maturation, IL-12 production, chemokine release, and T-helper polarization. Hum Vaccin Immunother (2014) 0.77
Factors associated with 2009 monovalent H1N1 vaccine coverage: a cross sectional study of 1,308 patients with psoriasis in France. Vaccine (2012) 0.77
Abatacept therapy and safety management. Joint Bone Spine (2012) 0.76
High frequency of cholestasis in generalized pustular psoriasis: Evidence for neutrophilic involvement of the biliary tract. Hepatology (2004) 0.76
B-cell lymphomas involving the skin associated with hepatitis C virus infection. Int J Dermatol (2002) 0.76
Optic neuritis associated with tumor necrosis factor-alfa antagonists for the treatment of psoriasis. J Am Acad Dermatol (2012) 0.76
Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis. Arch Dermatol (2012) 0.76
BRAF inhibitor rechallenge in patients with advanced BRAF V600-mutant melanoma. Melanoma Res (2015) 0.76
Psoriasis and phenotype of patients with early inflammatory back pain. Ann Rheum Dis (2012) 0.76
Thalidomide is ineffective in the treatment of lichen planopilaris. J Am Acad Dermatol (2004) 0.75
Successive sebopsoriasis, erysipelas and Koebner phenomenon. CMAJ (2010) 0.75
[Therapy algorithm for cutaneous T-cell lymphomas]. Ann Dermatol Venereol (2005) 0.75
Adult-onset Still's disease revealed by facial edema. J Am Acad Dermatol (2008) 0.75
Terbinafine-induced subacute cutaneous lupus erythematosus. Dermatology (2006) 0.75
Solar urticaria successfully treated with intravenous immunoglobulins. Dermatology (2009) 0.75
Remission of severe CD8(+) cytotoxic T cell skin infiltrative disease in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis (2010) 0.75
A prospective study on the evolution of the T-cell repertoire in patients with Sézary syndrome treated by extracorporeal photopheresis. Blood (2002) 0.75
Intravenous immunoglobulins in difficult-to-treat ulcerated livedoid vasculopathy: five cases and a literature review. Int J Dermatol (2013) 0.75
Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab. Arch Dermatol (2009) 0.75